When Verily unveiled $700 million in funding late last year, it said the cash would support its Covid-19 research. Some of those research plans are now taking shape. Verily, the life sciences division ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s ...

Can Legionnaires’ disease trigger long-term symptoms? Discover how Swiss scientists are following pneumonia survivors to uncover the real impact on health and wellbeing. Study: Long-term impacts of ...

Boca Raton, Florida, April 01, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (INMB) (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments ...

Renal outcomes and chimeric antigen receptor (CAR) T-cell therapy efficacy were unaffected by baseline renal status in a cohort of patients with diffuse large B cell lymphoma, but acute kidney injury ...

The Study to Assess Risk and Resilience in Servicemembers - Longitudinal Study (STARRS-LS) is a major research effort focused on self-harming behaviors and related behavioral health conditions in ...